Regional court dismisses vaccine damage claim against Biontech

Health - Regional court dismisses vaccine damage claim against Biontech

On Wednesday, the Rottweil Regional Court dismissed a lawsuit for alleged damage caused by a coronavirus vaccination. The plaintiff was a 58-year-old man. He accuses the vaccine manufacturer Biontech of causing almost complete blindness in his right eye as a result of a coronavirus vaccination. The man is demanding 150,000 euros in compensation for pain and suffering from the Mainz-based company and a declaration that he must be compensated for all further damages. However, the 2nd Civil Chamber did not consider the requirements for claims to be met, as the Regional Court announced. The plaintiff has one month to appeal against the ruling.

This is not the first case of its kind in Germany. Nor is it the first decision by a court in this context.

Read also:

• Will he be convicted as Jutta's murderer after 37 years?
• He also wanted to kill his cousin
• With live stream! Gawkers film dying man
• Is Saarland threatened with economic collapse?

1. Despite this recent dismissal in Baden-Württemberg, ongoing legal cases related to coronavirus vaccine side effects continue to be a contentious issue in courts across Germany.
2. The Rottweil Regional Court's decision follows a similar ruling in Rhineland-Palatinate, where another plaintiff claimed damage from a coronavirus vaccine produced by Biontech.
3. Critics argue that the judicial process in German courts, when it comes to vaccine damage claims, might not offer sufficient compensation for the physical and emotional turmoil caused by Covid-19 diseases.
4. Although defeat in the Rottweil Regional Court means the man from Mainz must wait a month to potentially appeal, other known vaccine manufacturers across Europe are also under scrutiny for their role in the devastating health situation caused by Coronavirus.
5. Unfortunately, the spread of this devastating virus and the resulting crush of Covid-19 diseases continue to place immense pressure on the already overwhelmed healthcare system in Germany.
6. Despite these challenges, Biontech remains one of Germany's leading biotechnological companies, dedicated to advancing promising medical research and finding effective solutions to major diseases, including Corona.

Source: www.stern.de